CS logo
small CS logo
Orszagos Onkologiai Intezet; Borgyogyaszati Osztaly

Budapest, Hungary

About Orszagos Onkologiai Intezet; Borgyogyaszati Osztaly


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
No rows

Clinical Trials at Orszagos Onkologiai Intezet; Borgyogyaszati Osztaly


During the past decade, Orszagos Onkologiai Intezet; Borgyogyaszati Osztaly conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
No rows

Rows per page:

0–0 of 0

Clinical Trials Sponsors and Collaborators


Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Orszagos Onkologiai Intezet; Borgyogyaszati Osztaly


According to Clinical.Site data, the most researched conditions in "Orszagos Onkologiai Intezet; Borgyogyaszati Osztaly" are "Advanced BRAFV600 Wild-type Melanoma" (1 trials), "Cancer" (1 trials), "Melanoma" (1 trials) and "Metastatic Melanoma" (1 trials). Many other conditions were trialed in "Orszagos Onkologiai Intezet; Borgyogyaszati Osztaly" in a lesser frequency.

Clinical Trials Intervention Types at Orszagos Onkologiai Intezet; Borgyogyaszati Osztaly


Most popular intervention types in "Orszagos Onkologiai Intezet; Borgyogyaszati Osztaly" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (4 trials), "Cobimetinib" (3 trials), "Vemurafenib" (2 trials), "Atezolizumab Placebo" (1 trials) and "Pembrolizumab" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Orszagos Onkologiai Intezet; Borgyogyaszati Osztaly


The vast majority of trials in "Orszagos Onkologiai Intezet; Borgyogyaszati Osztaly" are 4 trials for "All" genders.

Clinical Trials Status at Orszagos Onkologiai Intezet; Borgyogyaszati Osztaly


Currently, there are NaN active trials in "Orszagos Onkologiai Intezet; Borgyogyaszati Osztaly". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Orszagos Onkologiai Intezet; Borgyogyaszati Osztaly, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Orszagos Onkologiai Intezet; Borgyogyaszati Osztaly, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status